Status:
COMPLETED
Can Cholesterol Lowering Drugs Influence Circulating Omega-3 Fatty Acid Levels
Lead Sponsor:
University of Manitoba
Collaborating Sponsors:
Canadian Institutes of Health Research (CIHR)
Conditions:
Hypercholesterolemia
Hyperlipidemia
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The objective of this study is to determine if the administration of a cholesterol lowering drug like ezetimibe will reduce circulating omega-3 fatty acid (ALA) levels in patients with heart disease a...
Detailed Description
All patients will undergo drug therapy as required to treat their clinical symptoms including the use of other classes of cholesterol-lowering drugs like statins (that will not interfere with intestin...
Eligibility Criteria
Inclusion
- The subject is between 18-80 years old
- The subject lives in Winnipeg area
- The subject is willing to seize intake of oils/ salad dressings/ seafood
- The subject is willing to comply with the study schedule
Exclusion
- The subject had been taking flax oil in the last month
- The subject is not willing to undergo dietary restrictions
Key Trial Info
Start Date :
July 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2015
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00955227
Start Date
July 1 2009
End Date
December 1 2015
Last Update
May 12 2016
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Boniface General Hospital
Winnipeg, Manitoba, Canada, R2H 2A6
2
St. Boniface General Hospital Research Centre
Winnipeg, Manitoba, Canada